Case Report
BibTex RIS Cite

Candidemia due to Candida glabrata in a non-immunosuppressed hospitalized patient

Year 2022, Volume: 4 Issue: 4, 463 - 465, 22.10.2022
https://doi.org/10.38053/acmj.1148163

Abstract

Opportunistic fungal infections due to Candida species in immunosuppressed patients appearas significant causes of mortality and morbidity. Candida infections and candidemia can also be encounteredamong immunocompetent patients with underlying predisposing factors. This paper presents a 72-year-old diabetic male patient who developed candidemia due to Candida glabrata complex without any underlying immunosuppressive disease. The patient fully recovered after a total of 23 days of anidulafungin treatment.

Supporting Institution

-

Project Number

-

Thanks

-

References

  • Antinori S, Milazzo L, Sollima S, Galli M, Corbellino M. Candidemia and invasive candidiasis in adults: a narrative review. Eur J Intern Med 2016; 34: 21-8.
  • Pappas PG, Kauffman CA, Andes DR, et al. Clinical practice guideline for the management of candidiasis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis 2016; 62: e1–e50.
  • Zakhem AE, Istambouli R, Alkozah M, et al. Predominance of Candida glabrata among non-albicans Candida species in a 16-year study of candidemia at a tertiary care center in Lebanon. Pathogens 2021; 10: 82.
  • Lortholary O,Renaudat C, Sitbon K, et al. Worrisome trends in incidence and mortality of candidemia in intensive care units (Paris Area, 2002–2010). Intensive Care Med 2014; 40: 1303–12.
  • Colombo AL, Guimarães T, Sukienik T, et al. Prognostic factors and historical trends in the epidemiology of candidemia in critically ill patients: an analysis of five multicenter studies sequentially conducted over a 9-year period. Intensive Care Med 2014; 40: 1489–98.
  • Radhouane K, Bedioui A, Yedeas MD, et al. Brain abscess due to Candida glabrata in an immunocompetent patient. a case report with update and literature review. ID Cases 2020; 22: e00996.
  • Angel-Moreno A, Boronat M, Bolaños M, Carrillo A, González S, Pérez Arellano JL. Candida glabrata fungemia cured by antibiotic-lock therapy: case report and short review. J Infect 2005; 51: e85-7.
  • Colomba C, Trizzino M, Imburgia C, Madonia S, Siracusa L, Giammanco GM. Candida glabrata meningitis and endocarditis: a late severe complication of candidemia. Int J Infect Dis 2014; 29: 174-5.
  • Schiedo RM, Lavelle W, Sun MH. Lumbar spinal Candida glabrata treated without surgical intervention: a case report. Cureus 2017; 9: e1371.
  • Falcone M, TiseoG, TasciniC, et al. Assessment of risk factors for candidemia in non-neutropenic patients hospitalized in Internal Medicine wards: a multicenter study. Eur J Intern Med 2017; 41: 33-8.
  • Cheng YR, Lin LC, Young TG, Liu CE, Chen CH, Tsay RW. Risk factors for candidemia-related mortality at a medical center in central Taiwan. J Microbiol Immunol Infect 2006; 39: 155-61.
Year 2022, Volume: 4 Issue: 4, 463 - 465, 22.10.2022
https://doi.org/10.38053/acmj.1148163

Abstract

Project Number

-

References

  • Antinori S, Milazzo L, Sollima S, Galli M, Corbellino M. Candidemia and invasive candidiasis in adults: a narrative review. Eur J Intern Med 2016; 34: 21-8.
  • Pappas PG, Kauffman CA, Andes DR, et al. Clinical practice guideline for the management of candidiasis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis 2016; 62: e1–e50.
  • Zakhem AE, Istambouli R, Alkozah M, et al. Predominance of Candida glabrata among non-albicans Candida species in a 16-year study of candidemia at a tertiary care center in Lebanon. Pathogens 2021; 10: 82.
  • Lortholary O,Renaudat C, Sitbon K, et al. Worrisome trends in incidence and mortality of candidemia in intensive care units (Paris Area, 2002–2010). Intensive Care Med 2014; 40: 1303–12.
  • Colombo AL, Guimarães T, Sukienik T, et al. Prognostic factors and historical trends in the epidemiology of candidemia in critically ill patients: an analysis of five multicenter studies sequentially conducted over a 9-year period. Intensive Care Med 2014; 40: 1489–98.
  • Radhouane K, Bedioui A, Yedeas MD, et al. Brain abscess due to Candida glabrata in an immunocompetent patient. a case report with update and literature review. ID Cases 2020; 22: e00996.
  • Angel-Moreno A, Boronat M, Bolaños M, Carrillo A, González S, Pérez Arellano JL. Candida glabrata fungemia cured by antibiotic-lock therapy: case report and short review. J Infect 2005; 51: e85-7.
  • Colomba C, Trizzino M, Imburgia C, Madonia S, Siracusa L, Giammanco GM. Candida glabrata meningitis and endocarditis: a late severe complication of candidemia. Int J Infect Dis 2014; 29: 174-5.
  • Schiedo RM, Lavelle W, Sun MH. Lumbar spinal Candida glabrata treated without surgical intervention: a case report. Cureus 2017; 9: e1371.
  • Falcone M, TiseoG, TasciniC, et al. Assessment of risk factors for candidemia in non-neutropenic patients hospitalized in Internal Medicine wards: a multicenter study. Eur J Intern Med 2017; 41: 33-8.
  • Cheng YR, Lin LC, Young TG, Liu CE, Chen CH, Tsay RW. Risk factors for candidemia-related mortality at a medical center in central Taiwan. J Microbiol Immunol Infect 2006; 39: 155-61.
There are 11 citations in total.

Details

Primary Language English
Subjects Health Care Administration
Journal Section Case Report
Authors

Melek Sena Altun 0000-0002-5612-7305

Salih Cesur 0000-0003-4960-7375

Esra Kaya Kılıç 0000-0002-3270-4841

Cigdem Ataman Hatipoglu 0000-0002-1104-8232

Özlem Öztekin 0000-0001-5535-762X

Sami Kınıklı 0000-0002-9661-7851

Project Number -
Early Pub Date October 21, 2022
Publication Date October 22, 2022
Published in Issue Year 2022 Volume: 4 Issue: 4

Cite

AMA Altun MS, Cesur S, Kaya Kılıç E, Ataman Hatipoglu C, Öztekin Ö, Kınıklı S. Candidemia due to Candida glabrata in a non-immunosuppressed hospitalized patient. Anatolian Curr Med J / ACMJ / acmj. October 2022;4(4):463-465. doi:10.38053/acmj.1148163

TR DİZİN ULAKBİM and International Indexes (1b)

Interuniversity Board (UAK) Equivalency:  Article published in Ulakbim TR Index journal [10 POINTS], and Article published in other (excuding 1a, b, c) international indexed journal (1d) [5 POINTS]

Note: Our journal is not WOS indexed and therefore is not classified as Q.

You can download Council of Higher Education (CoHG) [Yüksek Öğretim Kurumu (YÖK)] Criteria) decisions about predatory/questionable journals and the author's clarification text and journal charge policy from your browser. https://dergipark.org.tr/tr/journal/3449/file/4924/show

Journal Indexes and Platforms: 

TR Dizin ULAKBİM, Google Scholar, Crossref, Worldcat (OCLC), DRJI, EuroPub, OpenAIRE, Turkiye Citation Index, Turk Medline, ROAD, ICI World of Journal's, Index Copernicus, ASOS Index, General Impact Factor, Scilit.


The indexes of the journal's are;

18596


asos-index.png

f9ab67f.png

WorldCat_Logo_H_Color.png

      logo-large-explore.png

images?q=tbn:ANd9GcQgDnBwx0yUPRKuetgIurtELxYERFv20CPAUcPe4jYrrJiwXzac8rGXlzd57gl8iikb1Tk&usqp=CAU

index_copernicus.jpg


84039476_619085835534619_7808805634291269632_n.jpg





The platforms of the journal's are;

COPE.jpg

images?q=tbn:ANd9GcTbq2FM8NTdXECzlOUCeKQ1dvrISFL-LhxhC7zy1ZQeJk-GGKSx2XkWQvrsHxcfhtfHWxM&usqp=CAUicmje_1_orig.png

cc.logo.large.png

ncbi.png

ORCID_logo.pngimages?q=tbn:ANd9GcQlwX77nfpy3Bu9mpMBZa0miWT2sRt2zjAPJKg2V69ODTrjZM1nT1BbhWzTVPsTNKJMZzQ&usqp=CAU


images?q=tbn:ANd9GcTaWSousoprPWGwE-qxwxGH2y0ByZ_zdLMN-Oq93MsZpBVFOTfxi9uXV7tdr39qvyE-U0I&usqp=CAU






The
 
indexes/platforms of the journal are;

TR Dizin Ulakbim, Crossref (DOI), Google Scholar, EuroPub, Directory of Research Journal İndexing (DRJI), Worldcat (OCLC), OpenAIRE, ASOS Index, ROAD, Turkiye Citation Index, ICI World of Journal's, Index Copernicus, Turk Medline, General Impact Factor, Scilit 


EBSCO, DOAJ, OAJI is under evaluation.

Journal articles are evaluated as "Double-Blind Peer Review"